GSK-813893

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameGSK-813893
Drug Alias Name813893GW-813893GSK-813893
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFactor Xa inhibitors
TargetsCoagulation factor X
Therapy Area/IndicationsVenous Thromboembolism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsVenous Thromboembolism

Other Information

ATC CodeN/A
Related LinksN/A